Ankit Nikhil Mehta MD FASN FACP (He/Him)

Nephrology•Dallas, TX

Program Director, Internal Medicine Residency, Baylor University Medical Center, Dallas, TX Clinical Associate Professor, Department of Internal Medicine, Texas A & M Health Science Center, College of Medicine, Dallas Campus.

Join to View Full Profile

411 N Washington Ave Ste 6000Dallas, TX 75246
Phone+1 214-358-2300
Fax+1 214-579-6988

Summary

Dr. Ankit Mehta is a nephrologist in Dallas, TX and is affiliated with Baylor University Medical Center. He received his medical degree from Grant Medical College and has been in practice 15 years. He also speaks multiple languages, including Hindi and Gujarati. He is experienced in hypertension, general nephrology, acute renal failure, chronic kidney disease, and transplant nephrology.

Ankit Nikhil Mehta, MD | Baylor Scott & White Health

Dr. Mehta is fellowship-trained and board-certified in nephrology and internal medicine. His professional interests include management of patients w

Ankit N. Mehta, MD, FASN at Dallas Nephrology Associates

Meet Ankit N. Mehta, MD, FASN, a Baylor-trained kidney specialist providing leading-edge care at the Dallas Landry office of Dallas Nephrology Associates.

Education & Training

Baylor University Medical CenterFellowship, Nephrology, 2008 - 2010
Baylor University Medical CenterResidency, Internal Medicine, 2005 - 2008
Grant Medical CollegeClass of 2002

Certifications & Licensure

TX State Medical License 2008 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Super Doctor SuperDoctors.com

Clinical Trials

Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function Start of enrollment: 2016 Jun 01
Completed
Phase 3
A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry Disease Start of enrollment: 2022 Mar 11
ACTIVE_NOT_RECRUITING
PHASE3
A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease Start of enrollment: 2022 May 03
ACTIVE_NOT_RECRUITING
PHASE3
Vonafexor ALPort Syndrome Efficacy & Safety TRIAl-1 (ALPESTRIA-1) Start of enrollment: 2024 Aug 01
ACTIVE_NOT_RECRUITING
PHASE2
A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure. Start of enrollment: 2024 Mar 29
RECRUITING
PHASE3
A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease Start of enrollment: 2024 Aug 08
RECRUITING
PHASE2
Join now to see all

Publications & Presentations

PubMed

1 citations
Estimated Glomerular Filtration Rate Slope as an Endpoint in Cardiovascular Trials.
Arsalan Hamid, Stephen J Greene, Ankit Mehta, Javed Butler, Muhammad Shahzeb Khan
Current Heart Failure Reports. 2024-08-01
Contrast-associated acute kidney injury prevention.
Ahmad Kasabali, Ankit Mehta
Proceedings. 2024-01-01
6 citations
Alirocumab and Lipid Levels, Inflammatory Biomarkers, Metabolomics, and Safety in Patients Receiving Maintenance Dialysis: The ALIrocumab in DIALysis Study (A Phase 3 ...
Cara East, Kyle Bass, Ankit Mehta, Gelareh Rahimighazikalayed, Sandy Zurawski
Kidney Medicine. 2022-07-01

Professional Memberships

American Society of Nephrology - ASN
Fellow

Other Languages

Hindi, Gujarati